Annual Revenue
$7.53 M
-$87.06 M-92.04%
31 December 2023
Summary:
Cytokinetics Incorporated annual revenue is currently $7.53 million, with the most recent change of -$87.06 million (-92.04%) on 31 December 2023. During the last 3 years, it has fallen by -$48.30 million (-86.51%). CYTK annual revenue is now -92.92% below its all-time high of $106.41 million, reached on 31 December 2016.CYTK Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$463.00 K
+$214.00 K+85.94%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly revenue is currently $463.00 thousand, with the most recent change of +$214.00 thousand (+85.94%) on 30 September 2024. Over the past year, it has increased by +$85.00 thousand (+22.49%). CYTK quarterly revenue is now -99.48% below its all-time high of $88.97 million, reached on 30 June 2022.CYTK Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$3.22 M
+$85.00 K+2.71%
30 September 2024
Summary:
Cytokinetics Incorporated TTM revenue is currently $3.22 million, with the most recent change of +$85.00 thousand (+2.71%) on 30 September 2024. Over the past year, it has dropped by -$4.60 million (-58.81%). CYTK TTM revenue is now -97.87% below its all-time high of $151.15 million, reached on 30 June 2022.CYTK TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -92.0% | +22.5% | -58.8% |
| 3 y3 years | -86.5% | -91.5% | -85.1% |
| 5 y5 years | -76.1% | -92.3% | -89.6% |
CYTK Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -92.0% | at low | -99.5% | +85.9% | -97.9% | +2.7% |
| 5 y | 5 years | -92.0% | at low | -99.5% | +85.9% | -97.9% | +2.7% |
| alltime | all time | -92.9% | +192.2% | -99.5% | +2672.2% | -97.9% | +28.8% |
Cytokinetics Incorporated Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $463.00 K(+85.9%) | $3.22 M(+2.7%) |
| June 2024 | - | $249.00 K(-70.2%) | $3.13 M(-16.5%) |
| Mar 2024 | - | $835.00 K(-50.1%) | $3.75 M(-50.2%) |
| Dec 2023 | $7.53 M(-92.0%) | $1.67 M(+342.3%) | $7.53 M(-3.6%) |
| Sept 2023 | - | $378.00 K(-56.4%) | $7.82 M(-21.5%) |
| June 2023 | - | $867.00 K(-81.2%) | $9.95 M(-89.9%) |
| Mar 2023 | - | $4.61 M(+135.7%) | $98.05 M(+3.7%) |
| Dec 2022 | $94.59 M(+34.3%) | $1.96 M(-22.2%) | $94.59 M(-36.2%) |
| Sept 2022 | - | $2.52 M(-97.2%) | $148.23 M(-1.9%) |
| June 2022 | - | $88.97 M(+7649.8%) | $151.15 M(+132.4%) |
| Mar 2022 | - | $1.15 M(-97.9%) | $65.03 M(-7.7%) |
| Dec 2021 | $70.43 M(+26.2%) | $55.60 M(+922.6%) | $70.43 M(+226.8%) |
| Sept 2021 | - | $5.44 M(+91.2%) | $21.55 M(-62.7%) |
| June 2021 | - | $2.84 M(-56.6%) | $57.80 M(-1.3%) |
| Mar 2021 | - | $6.55 M(-2.6%) | $58.55 M(+4.9%) |
| Dec 2020 | $55.83 M(+107.8%) | $6.72 M(-83.9%) | $55.83 M(+2.8%) |
| Sept 2020 | - | $41.69 M(+1060.3%) | $54.32 M(+190.7%) |
| June 2020 | - | $3.59 M(-6.1%) | $18.68 M(-15.9%) |
| Mar 2020 | - | $3.83 M(-26.6%) | $22.23 M(-17.3%) |
| Dec 2019 | $26.87 M(-14.7%) | $5.21 M(-13.9%) | $26.87 M(-13.4%) |
| Sept 2019 | - | $6.05 M(-15.2%) | $31.03 M(-12.9%) |
| June 2019 | - | $7.14 M(-15.7%) | $35.62 M(+2.7%) |
| Mar 2019 | - | $8.46 M(-9.7%) | $34.70 M(+10.1%) |
| Dec 2018 | $31.50 M(+135.6%) | $9.38 M(-11.9%) | $31.50 M(+42.5%) |
| Sept 2018 | - | $10.64 M(+71.2%) | $22.11 M(+25.3%) |
| June 2018 | - | $6.21 M(+18.0%) | $17.64 M(+21.8%) |
| Mar 2018 | - | $5.27 M(<-9900.0%) | $14.48 M(+8.3%) |
| Dec 2017 | $13.37 M(-87.4%) | -$18.00 K(-100.3%) | $13.37 M(-71.3%) |
| Sept 2017 | - | $6.18 M(+102.4%) | $46.52 M(-53.2%) |
| June 2017 | - | $3.05 M(-26.5%) | $99.39 M(-2.7%) |
| Mar 2017 | - | $4.15 M(-87.5%) | $102.14 M(-4.0%) |
| Dec 2016 | $106.41 M(+271.3%) | $33.14 M(-43.9%) | $106.41 M(+28.2%) |
| Sept 2016 | - | $59.05 M(+917.7%) | $83.03 M(+160.1%) |
| June 2016 | - | $5.80 M(-31.1%) | $31.93 M(-2.3%) |
| Mar 2016 | - | $8.42 M(-13.7%) | $32.66 M(+14.0%) |
| Dec 2015 | $28.66 M(-38.9%) | $9.76 M(+22.8%) | $28.66 M(-29.5%) |
| Sept 2015 | - | $7.95 M(+21.4%) | $40.66 M(-3.5%) |
| June 2015 | - | $6.54 M(+48.2%) | $42.13 M(-2.9%) |
| Mar 2015 | - | $4.41 M(-79.7%) | $43.38 M(-7.6%) |
| Dec 2014 | $46.94 M(+53.2%) | $21.76 M(+131.1%) | $46.94 M(-5.2%) |
| Sept 2014 | - | $9.41 M(+20.9%) | $49.53 M(+11.1%) |
| June 2014 | - | $7.79 M(-2.4%) | $44.59 M(+17.9%) |
| Mar 2014 | - | $7.98 M(-67.2%) | $37.81 M(+23.4%) |
| Dec 2013 | $30.65 M | $24.35 M(+444.8%) | $30.65 M(+261.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | - | $4.47 M(+342.9%) | $8.48 M(+48.1%) |
| June 2013 | - | $1.01 M(+22.9%) | $5.73 M(-12.7%) |
| Mar 2013 | - | $821.00 K(-62.4%) | $6.56 M(-13.2%) |
| Dec 2012 | $7.56 M(+89.0%) | $2.18 M(+27.4%) | $7.56 M(+23.3%) |
| Sept 2012 | - | $1.71 M(-6.9%) | $6.13 M(+4.9%) |
| June 2012 | - | $1.84 M(+1.2%) | $5.84 M(+15.6%) |
| Mar 2012 | - | $1.82 M(+140.4%) | $5.06 M(+26.4%) |
| Dec 2011 | $4.00 M(+55.2%) | $757.00 K(-47.0%) | $4.00 M(-7.9%) |
| Sept 2011 | - | $1.43 M(+35.5%) | $4.34 M(+31.2%) |
| June 2011 | - | $1.05 M(+38.0%) | $3.31 M(+21.7%) |
| Mar 2011 | - | $763.00 K(-30.6%) | $2.72 M(+5.5%) |
| Dec 2010 | $2.58 M(-96.8%) | $1.10 M(+178.9%) | $2.58 M(+3.0%) |
| Sept 2010 | - | $394.00 K(-14.7%) | $2.50 M(-67.2%) |
| June 2010 | - | $462.00 K(-25.6%) | $7.61 M(-90.4%) |
| Mar 2010 | - | $621.00 K(-39.3%) | $79.08 M(-3.0%) |
| Dec 2009 | $81.54 M(+556.5%) | $1.02 M(-81.4%) | $81.54 M(-2.5%) |
| Sept 2009 | - | $5.51 M(-92.3%) | $83.67 M(+2.9%) |
| June 2009 | - | $71.93 M(+2236.9%) | $81.28 M(+554.0%) |
| Mar 2009 | - | $3.08 M(-2.3%) | $12.43 M(+0.1%) |
| Dec 2008 | $12.42 M(-8.8%) | $3.15 M(+0.9%) | $12.42 M(+0.3%) |
| Sept 2008 | - | $3.13 M(+1.7%) | $12.38 M(-7.5%) |
| June 2008 | - | $3.07 M(+0.2%) | $13.38 M(-0.8%) |
| Mar 2008 | - | $3.07 M(-1.3%) | $13.49 M(-1.0%) |
| Dec 2007 | $13.62 M(+335.6%) | $3.11 M(-24.7%) | $13.62 M(+27.7%) |
| Sept 2007 | - | $4.13 M(+30.0%) | $10.67 M(+60.6%) |
| June 2007 | - | $3.18 M(-0.9%) | $6.64 M(+35.2%) |
| Mar 2007 | - | $3.21 M(+1967.7%) | $4.91 M(+57.1%) |
| Dec 2006 | $3.13 M(-64.9%) | $155.00 K(+46.2%) | $3.13 M(-38.9%) |
| Sept 2006 | - | $106.00 K(-92.7%) | $5.12 M(-25.5%) |
| June 2006 | - | $1.45 M(+1.8%) | $6.87 M(-11.5%) |
| Mar 2006 | - | $1.42 M(-33.8%) | $7.76 M(-12.9%) |
| Dec 2005 | $8.91 M(-33.7%) | $2.14 M(+15.6%) | $8.91 M(-0.9%) |
| Sept 2005 | - | $1.85 M(-20.8%) | $8.99 M(-6.2%) |
| June 2005 | - | $2.34 M(-9.0%) | $9.59 M(-5.5%) |
| Mar 2005 | - | $2.57 M(+15.5%) | $10.15 M(-24.5%) |
| Dec 2004 | $13.44 M(+27.1%) | $2.23 M(-9.1%) | $13.44 M(-3.0%) |
| Sept 2004 | - | $2.45 M(-15.6%) | $13.86 M(-1.4%) |
| June 2004 | - | $2.90 M(-50.6%) | $14.05 M(+2.5%) |
| Mar 2004 | - | $5.87 M(+121.9%) | $13.71 M(+29.4%) |
| Dec 2003 | $10.58 M(-7.2%) | $2.64 M(0.0%) | $10.59 M(+33.3%) |
| Sept 2003 | - | $2.64 M(+3.5%) | $7.95 M(+49.9%) |
| June 2003 | - | $2.55 M(-7.1%) | $5.30 M(+92.9%) |
| Mar 2003 | - | $2.75 M | $2.75 M |
| Dec 2002 | $11.40 M(+34.6%) | - | - |
| Dec 2001 | $8.47 M | - | - |
FAQ
- What is Cytokinetics Incorporated annual revenue?
- What is the all time high annual revenue for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual revenue year-on-year change?
- What is Cytokinetics Incorporated quarterly revenue?
- What is the all time high quarterly revenue for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly revenue year-on-year change?
- What is Cytokinetics Incorporated TTM revenue?
- What is the all time high TTM revenue for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM revenue year-on-year change?
What is Cytokinetics Incorporated annual revenue?
The current annual revenue of CYTK is $7.53 M
What is the all time high annual revenue for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual revenue is $106.41 M
What is Cytokinetics Incorporated annual revenue year-on-year change?
Over the past year, CYTK annual revenue has changed by -$87.06 M (-92.04%)
What is Cytokinetics Incorporated quarterly revenue?
The current quarterly revenue of CYTK is $463.00 K
What is the all time high quarterly revenue for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly revenue is $88.97 M
What is Cytokinetics Incorporated quarterly revenue year-on-year change?
Over the past year, CYTK quarterly revenue has changed by +$85.00 K (+22.49%)
What is Cytokinetics Incorporated TTM revenue?
The current TTM revenue of CYTK is $3.22 M
What is the all time high TTM revenue for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM revenue is $151.15 M
What is Cytokinetics Incorporated TTM revenue year-on-year change?
Over the past year, CYTK TTM revenue has changed by -$4.60 M (-58.81%)